---
figid: PMC5451507__fcvm-04-00036-g002
figtitle: 'Congenital heart defect BioCore (CHD-BioCore): strategy and frame work'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5451507
filename: fcvm-04-00036-g002.jpg
figlink: /pmc/articles/PMC5451507/figure/F2/
number: F2
caption: 'The congenital heart defect BioCore (CHD-BioCore): strategy and frame work.
  Illustration of the strategic framework for the CHD BioCore: (1) Proper delineation
  of the phenotypic spectrum of CHDs. (2) Defining the molecular genotype/phenotype
  by combining whole-exome sequencing (WES) and transcriptome analysis. (3) Integration
  of phenotypic and molecular datasets to identify distinct molecular function networks
  associated with CHD phenotypes. (4) Integration of genomic data by mapping the putative
  variants to the molecular networks for mutation prioritization or pathway identification.
  (5) Mechanistic validation in relevant disease models and human induced pluripotent
  stem cells (iPSCs) for translational application.'
papertitle: A Path to Implement Precision Child Health Cardiovascular Medicine.
reftext: Marlin Touma, et al. Front Cardiovasc Med. 2017;4:36.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6204645
figid_alias: PMC5451507__F2
figtype: Figure
redirect_from: /figures/PMC5451507__F2
ndex: 4ae4c762-df31-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5451507__fcvm-04-00036-g002.html
  '@type': Dataset
  description: 'The congenital heart defect BioCore (CHD-BioCore): strategy and frame
    work. Illustration of the strategic framework for the CHD BioCore: (1) Proper
    delineation of the phenotypic spectrum of CHDs. (2) Defining the molecular genotype/phenotype
    by combining whole-exome sequencing (WES) and transcriptome analysis. (3) Integration
    of phenotypic and molecular datasets to identify distinct molecular function networks
    associated with CHD phenotypes. (4) Integration of genomic data by mapping the
    putative variants to the molecular networks for mutation prioritization or pathway
    identification. (5) Mechanistic validation in relevant disease models and human
    induced pluripotent stem cells (iPSCs) for translational application.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - seq
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Akt
  - bnl
  - Pten
  - Abl
  - Egfr
  - Src42A
  - Csk
  - Src64B
  - Fak
  - AKT1
  - AKT2
  - AKT3
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - PTEN
  - ABL1
  - MTTP
  - DSP-AS1
  - ABL2
  - PGF
  - EGFR
  - SRC
  - FGR
  - FYN
  - YES1
  - PTK2
  - IMPACT
  - GSKIP
  - Cancer
---
